Exploring genetic causes of rare diseases using advanced genomic techniques

Stanford Mendelian Genomics Research Center

NIH-funded research Stanford University · NIH-11078340

This study is looking for hidden genetic causes of rare inherited diseases in people who have symptoms but haven't yet been diagnosed, using advanced technology to help find answers that could lead to better treatments.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-11078340 on NIH RePORTER

What this research studies

This research focuses on identifying genetic variants responsible for rare Mendelian diseases by utilizing cutting-edge genomic technologies. It aims to analyze a cohort of individuals who have not yet received a genetic diagnosis despite showing symptoms of a Mendelian disorder. The study employs a combination of long-read whole genome sequencing, RNA-sequencing, and various epigenomic and metabolomic assays, alongside innovative computational methods for better gene and phenotype matching. By integrating these approaches, the research seeks to uncover new disease genes and variants that could lead to improved diagnosis and treatment options for patients.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with undiagnosed rare genetic diseases who exhibit symptoms consistent with Mendelian disorders.

Not a fit: Patients with well-characterized genetic conditions or those who have already received a definitive diagnosis may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly increase the rate of genetic diagnoses for individuals with rare diseases, leading to more targeted and effective treatments.

How similar studies have performed: Previous research has shown promising results using similar genomic approaches, indicating a strong potential for success in this novel application.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.